DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Supply & Logistics for Pharmaceutical Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering.
The Global Clinical Trial Supply & Logistics for Pharmaceutical Market is projected to reach USD 30.59 billion by 2027 from USD 19.60 billion in 2021, at a CAGR 7.69% during the forecast period.
The report on clinical trial supply & logistics for pharmaceutical identifies key attributes about the customer to define the potential market and identify different needs across the industry.
Understanding the potential customer group’s economies and geographies can help gain business acumen for better strategic decision-making. This market coverage across different industry verticals reveals the hidden truth about the players’ strategies in different verticals and helps the organization decide target audience.
This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.
In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Key Findings
- The Americas Clinical Trial Supply & Logistics for Pharmaceutical Market size was estimated at USD 7,698.04 million in 2021, is expected to reach USD 8,279.20 million in 2022, and is projected to grow at a CAGR of 7.65% to reach USD 11,983.99 million by 2027.
- The Asia-Pacific Clinical Trial Supply & Logistics for Pharmaceutical Market size was estimated at USD 4,383.33 million in 2021, is expected to reach USD 4,760.30 million in 2022, and is projected to grow at a CAGR of 7.99% to reach USD 6,955.17 million by 2027.
- The Europe, Middle East & Africa Clinical Trial Supply & Logistics for Pharmaceutical Market size was estimated at USD 7,526.48 million in 2021, is expected to reach USD 8,072.82 million in 2022, and is projected to grow at a CAGR of 7.55% to reach USD 11,654.56 million by 2027.
Company Usability Profiles:
- Almac Group
- AmerisourceBergen Corporation
- Bilcare Limited
- Biocair International Limited
- Catalent, Inc.
- Clinigen Group PLC
- DHL International GmbH by Deutsche Post AG
- Eurofins Scientific SE
- FedEx Corporation
- ICON PLC
- Infosys Limited
- KLIFO A/S
- Lonza Group
- Marken
- Metrics Contract Services by Mayne Pharma group
- Movianto
- N-Side
- Parexel International Corporation
- PCI Pharma Services
- Seveillar Clinical Trial Supplies Pvt. Ltd.
- SIRO Clinpharm Private Limited
- Thermo Fisher Scientific, Inc.
- UDG Healthcare PLC
Market Segmentation & Coverage:
Phase:
- BA/BE Studies
- Phase I
- Phase II
- Phase III
- Phase IV
Sector:
- Clinical Trial Logistics and Distributions
- Clinical Trial Manufacturing Services
- Clinical Trial Supply Chain Management
Therapeutic Area:
- Blood Disorders
- Digestive System Diseases
- Infectious and Immune System Diseases
- Neurological and Mental Disorders
- Oncology
Region:
-
Americas
- Argentina
- Brazil
- Canada
- Mexico
-
United States
- Arizona
- California
- Florida
- Illinois
- New York
- North Carolina
- Ohio
- Oregon
- Pennsylvania
- Tennessee
- Texas
-
Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
-
Europe, Middle East & Africa
- France
- Germany
- Italy
- Netherlands
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- United Arab Emirates
- United Kingdom
For more information about this report visit https://www.researchandmarkets.com/r/pp038v
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900